CRSP
Price
$70.66
Change
-$0.95 (-1.33%)
Updated
Nov 28, 6:59 PM EST
76 days until earnings call
RAPT
Price
$14.26
Change
+$0.43 (+3.11%)
Updated
Nov 28, 6:59 PM EST
99 days until earnings call
Ad is loading...

Compare trend and price CRSP vs RAPT

Header iconCRSP vs RAPT Comparison
Open Charts CRSP vs RAPTBanner chart's image
CRISPR Therapeutics AG
Price$70.66
Change-$0.95 (-1.33%)
Volume$970.86K
CapitalizationN/A
RAPT Therapeutics
Price$14.26
Change+$0.43 (+3.11%)
Volume$68.21K
CapitalizationN/A
View a ticker or compare two or three
CRSP vs RAPT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CRSP vs. RAPT commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and RAPT is a StrongBuy.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (CRSP: $70.66 vs. RAPT: $14.26)
Brand notoriety: CRSP and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 95% vs. RAPT: 37%
Market capitalization -- CRSP: $5.69B vs. RAPT: $475.7M
CRSP [@Biotechnology] is valued at $5.69B. RAPT’s [@Biotechnology] market capitalization is $475.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 0 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 0 bullish, 1 bearish.
  • RAPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CRSP and RAPT are a bad buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а +4.57% price change this week, while RAPT (@Biotechnology) price change was +4.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.68%. For the same industry, the average monthly price growth was +33.10%, and the average quarterly price growth was +8.38%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 13, 2024.

RAPT is expected to report earnings on Mar 07, 2024.

Industries' Descriptions

@Biotechnology (+1.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRSP with price predictions.
OPEN
A.I.dvisor published
a Summary for RAPT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRSP($5.69B) has a higher market cap than RAPT($476M). CRSP YTD gains are higher at: 73.825 vs. RAPT (-27.980). RAPT has higher annual earnings (EBITDA): -117.13M vs. CRSP (-402.88M). CRSP has more cash in the bank: 1.74B vs. RAPT (185M). RAPT has less debt than CRSP: RAPT (7.46M) vs CRSP (242M). CRSP has higher revenues than RAPT: CRSP (170M) vs RAPT (0).
CRSPRAPTCRSP / RAPT
Capitalization5.69B476M1,195%
EBITDA-402.88M-117.13M344%
Gain YTD73.825-27.980-264%
P/E Ratio20.92N/A-
Revenue170M0-
Total Cash1.74B185M941%
Total Debt242M7.46M3,243%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
15

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPRAPT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend about 1 month ago
83%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend about 1 month ago
84%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend about 1 month ago
83%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTCBX42.600.06
+0.14%
MFS Technology B
MSFJX18.900.01
+0.05%
MFS Total Return R4
HWACX32.44N/A
N/A
Hotchkis & Wiley Value Opps C
REAYX24.87-0.03
-0.12%
Russell Inv Equity Income Y
RYRHX43.71-0.20
-0.46%
Rydex Russell 2000 H

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
+3.11%
BEAM - RAPT
49%
Loosely correlated
+2.09%
DNLI - RAPT
48%
Loosely correlated
+2.12%
AXON - RAPT
48%
Loosely correlated
-0.48%
VCYT - RAPT
47%
Loosely correlated
-2.24%
CRSP - RAPT
46%
Loosely correlated
-1.33%
More